Tumor markers in pleural effusions

Ondrej Topolcan, L. Holubec, V. Polivkova, S. Svobodova, M. Pesek, V. Treska, J. Safranek, T. Hajek, L. Bartunek, M. Rousarova, J. Finek

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

Aim: The aim of this study was to determine the diagnostic capabilities of tumor markers in pleural effusion and their importance for assessment of the etiology of pleural effusions. Patients and Methods: In pleural effusions from 166 patients hospitalized during the period 2003-2005 at the Department of Oncology and Radiotherapy, Faculty Hospital in Pilsen, the following tumor markers were determined: thymidine kinase (TK), neuron-specific enolase (NSE), cytokeratins [tissue polypeptide antigen (TPA), tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 19 (CYFRA 21-1)], carcinoembryonic antigen (CEA) and mucinous markers (CA 15-3, CA 19-9, CA 125). The inflammatory marker procalcitonin-PCT was also assessed. Results: Tumor markers CA 125, TPA, TPS were significantly elevated in exudates, irrespective of the etiology, as a non-specific reaction in mesothelial cells. TK had a sensitivity of over 80% for all the types of cancer examined, while CA 15-3 had a sensitivity of over 90%. Conclusion: Significant positivity of PCT and CA 15-3 in pleural effusions indicate a suspicion of inflammatory disease. Positivity of TK and CA 15-3 indicate a strong suspicion of malignant exudates.

Original languageEnglish
Pages (from-to)1921-1924
Number of pages4
JournalAnticancer Research
Volume27
Issue number4 A
Publication statusPublished - Jul 2007
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Tumor markers in pleural effusions'. Together they form a unique fingerprint.

Cite this